Sign in
Enrolling by invitationNo phase

Study of people with REM sleep behavior disorder who may develop Parkinson disease

Enrolls people with a sleep disorder linked to Parkinson-type brain diseases to prepare future trials.

Key facts

Who runs it
Washington University School of Medicine
Where
Atlanta, Boston, Los Angeles, Minneapolis, Portland, Redwood City, Rochester, St Louis, and Sun City, United StatesSee the 9 sitesAlso in 1 other country, 1 site
Trial code
Registry title
North American Prodromal Synucleinopathy Consortium
Status
Enrolling by invitation
People taking part
500 people, planned
Started
29 Aug 2018
Planned end
31 Jul 2026
Type of study
Observational
Record updated
6 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with idiopathic REM sleep behavior disorder (RBD), to prepare for a later trial of treatments that protect the nerves.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Idiopathic REM sleep behavior disorder (no other known cause).

Main reasons for not taking part

  • REM sleep behavior disorder caused by another condition (for example narcolepsy, dementia, Parkinson's Disease)
  • Another neurological disorder

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Idiopathic REM sleep behavior disorder

Who cannot take part

  • REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc)
  • Other neurological disorder

Where in United States

Also in 1 other country, 1 site

  • Emory UniversityAtlanta, United StatesEnrolling by invitation
  • Massachusetts General HospitalBoston, United StatesEnrolling by invitation
  • University of California, Los AngelesLos Angeles, United StatesEnrolling by invitation
  • University of MinnesotaMinneapolis, United StatesEnrolling by invitation
  • Portland VA Medical CenterPortland, United StatesEnrolling by invitation
  • Stanford UniversityRedwood City, United StatesEnrolling by invitation
  • Mayo ClinicRochester, United StatesEnrolling by invitation
  • Washington UniversitySt Louis, United StatesEnrolling by invitation
  • Banner Sun Health Research InstituteSun City, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
North American Prodromal Synucleinopathy Consortium
Plain-language title
Study of people with REM sleep behavior disorder who may develop Parkinson diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
6 November 2024